More
    Guided Solutions - Connecting Talent With Innovation/div>

    SonoMind raises $23.5M for focused ultrasound-based depression therapy

    Sonomind announced that it raised $23.5 million (€20 million) in its Series A funding round led by Critical Path Ventures and Bpifrance. The French startup specializes in non-invasive, painless therapy for mental illnesses using focused...

    SonoMind raises $23.5M for focused ultrasound-based depression therapy

    Sonomind announced that it raised $23.5 million (€20 million) in its Series A funding round led by Critical Path Ventures and Bpifrance. The French startup...

    Aurie wins FDA nod for reusable intermittent catheter system

    Aurie announced that it received FDA de novo clearance for its Aurie Reusable No-Touch Intermittent Catheter System. The Syracuse, New York-based company says the milestone...

    FDA clears Bright Uro’s abdominal sensor for evaluating bladder dysfunction

    Bright Uro’s Glean abdominal sensor has obtained US Food and Drug Administration (FDA) clearance, expanding the company’s broader Glean urodynamics system to include multi-channel...

    Reprieve Cardiovascular pilot study backs heart failure system

    Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy. Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Reprieve Cardiovascular pilot study backs heart failure system

    Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy. Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...

    MMI completes first robotic-assisted procedure in Alzheimer’s patient

    Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...

    CVRx enrolls first patient in study of Barostim therapy for heart failure

    CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy. Barostim delivers electrical pulses to baroreceptors in the...

    Sensome reports positive findings for clot-sensing guidewire

    Sensome announced the publication of first-in-human results from the CLOT OUT study evaluating its Clotild smart guidewire system. Findings published in the Journal of Neurointerventional...

    Innovation

    Regulatory Approvals

    SonoMind raises $23.5M for focused ultrasound-based depression therapy

    Sonomind announced that it raised $23.5 million (€20 million) in its Series A funding round led by Critical Path Ventures and Bpifrance. The French startup...

    Aurie wins FDA nod for reusable intermittent catheter system

    Aurie announced that it received FDA de novo clearance for its Aurie Reusable No-Touch Intermittent Catheter System. The Syracuse, New York-based company says the milestone...

    FDA clears Bright Uro’s abdominal sensor for evaluating bladder dysfunction

    Bright Uro’s Glean abdominal sensor has obtained US Food and Drug Administration (FDA) clearance, expanding the company’s broader Glean urodynamics system to include multi-channel...

    Reprieve Cardiovascular pilot study backs heart failure system

    Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy. Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...

    M&A

    Archives

    Latest articles